INFLUENCE OF NEUROPROTECTORY DRUGS ON POST-TRAUMATIC ENCEPHALOPATHY
Keywords:
post-traumatic encephalopathy, neuroprotectors, cytocoline, nerve cells.Abstract
This article reviews the use of neuroprotective drugs for the treatment of post-traumatic encephalopathy (PTE). PTE is a progressive neurodegenerative disease that can develop after traumatic brain injury.
Neuroprotective drugs are medications that can protect nerve cells from damage. The article discusses various neuroprotectants that are currently being studied for the treatment of PTE, including citicoline, choline alfoscerate, and mildronate. The author also considers the feasibility of using neuroprotectors for severe brain injuries. They note that there are currently no medications that can completely prevent or cure PTE, but neuroprotectants may help slow the progression of the disease and improve patients' quality of life.
This article is a review that summarizes current knowledge on the role of neuroprotective drugs in the treatment of PTE. It will be useful for doctors, researchers and patients interested in this topic.
References
Bachinskaya N.Yu. Neuropsychological and neurophysiological aspects of the syndrome of moderate cognitive impairment / N.Yu. Bachinskaya, V.A. Kholin, K.N. Poletaeva, A.A. Shul-kevich // Ukratsky vknik psychoneurologists. - 2007. - T. 15, VIP. 1(50), supplement. — P. 18.
Belenichev I.F. Nootropic therapy: past, present, future/I.F. Belenichev, I.A. Mazur, V.R. Stets // News of medicine and pharmacy. - 2004. - No. 15(155). — P. 10.
Burchinsky S.G. Possibilities and prospects of nootropic drugs for dyscirculatory encephalopathy / S.G. Burchinsky // Journal. practical doctor. - 2005. - No. 2. - P. 51-55.
Gusev E.I. Cerebral ischemia/Gusev E.I., Skvortsov V.I. - M.: Medicine, 2007. - 328 p.
Golik V.A. Renaissance of nootropic therapy: from origins to new areas of clinical use of nootropics for diseases of the central nervous system // Neuron-review. - 2012. - No. 2. - P. 2-22.
Dzyak L.A. The effectiveness of thiocetam in the treatment of dyscirculatory encephalopathies due to atherosclerotic damage to the cerebral arteries // News of medicine and pharmacy. - 2004. - No. 10-11. — P. 4-5.
Zakharov V.V. Treatment of mild and moderate cognitive impairment//Russian Medical Journal. - 2007. - No. 10. - P. 797-801.
Evtushenko S.K. and others. 10 years of experience in the use of Cerebrocurin in the treatment of organic diseases of the nervous system in children // MNZH. - 2010. - No. 3. - P. 12-18.
Kuznetsova S.M. The effect of thiocetam on the functional state of patients who have suffered an ischemic stroke / Kuznetsova S.M., Kuznetsov V.V., Vorobey V.M. // International neurological journal. - 2005. - No. 1. - P. 45-51.
Levin O.S.The use of cytocoline in the treatment of stroke / Levin O.S.//Rus.med. magazine - 2008. - No. 26. — S. 1772-1777.
Clinical pharmacology with elements of clinical biochemistry. Guide for doctors and clinical pharmacists / Ed. S.V. Nagieva, T.D. Bakhteeva, I.A. Zupanca. - Donetsk: Noumedgi, 2011. - 930 p.
Mishchenko T.S. New targets for therapeutic intervention in patients with chronic cerebral ischemia / Mishchenko T.S., Zdesenko I.V., Linskaya A.V., Mishchenko V.N. // International neurological journal. — 2011. — No. 2(40). — P. 7-17.
Skvortsova V.I. Neuroprotective therapy with cytocoline in the acute period of cerebral stroke / Skvortsov V.I., Boytsova A. // Doctor. - 2007. - No. 12. - P. 25-28.
Cherny V.I. Cerebral ischemia in critical care medicine. Neuroprotection (pathophysiology, terminology, characteristics of drugs): Method. rec. / IN AND. Cherny, A.N. Kolesnikov, G.A. Gorodnik. - Kyiv, 2007. - 72 p.
Evtushenko 1.S.
Adibhatla R.M. Citicoline: Neuroprotective mechanisms in cerebral ischemia/Adibhatla R.M., Hatcher J.F., Dempsey R.I. // J. Neurochem. - 2002. - 80. - 12-13.
Cacabelos R. Therapeutic effects of CDPcholine in Alzheimer's disease and multi-infarct dementia // Cacabelos R., Alvarez X.A., Franco A. et al. //Ann. Psychiat. - 2006. - No. 3. - P. 233-245.
Giurgea C. The nootropic approach to the phermocology of the integrative activity of the brain // Cond. Reflex. - 2003. - No. 8(2). - 108-115.
Cobo E. Boosting the chances to improve stroke treatment/ Cobo E, Secades J.J., Miras F. et al. //Stroke. - 2010. - No. 41. - P. 143-150.
Newpher T.M., Ehlers M.D. Glutamate receptor dynamics in dendritic microdomains//Neuron. — 2006, may22. — 58(4). — 472-497.
Hacke W. Acute Treatment of Ischemic Stroke/ W. Hacke, M. Kaste, T. Skyhoi Olsen et al. // Cerebrovascular Diseases. — 2000. — № 10. — P. 1-11.
Malykh A.G., Sadaie M.R. Piracetam andpiracetam-Like grugs. From Basic Science to Novel Cliniical applications to CNS Disorders // D
Narzullayeva O.М., Sanoev B.A. Dercum's Disease (Neurolipomatosis) as Concomitant Disease in Autopsy Practice 2023; 33-40. Retrieved from https://medicaljournals.eu/index.php/IJIMM/article/view/93
Саноев Б.А., Нарзуллаева О. М. Volume: 02 Issue: 11 | Nov – 2023 ISSN: 2720-6866 Retrieved from
http://journals.academiczone.net/index.php/rjtds
Narzullayeva O.М., Sanoev B.A. Morphological Features of Ovarian Neoplasms. 2023; 41-46 Retrieved from http://medicaljournals.eu/index.php/IJIMM/issue/view/3
Narzullayeva O.М. The Effect of Stress on the Morphology of the Thyroid Gland 1(10), 834–839. Retrieved from https://grnjournal.us/index.php/AJPMHS/article/view/2447
